The Net Margin of Myungmoon Pharm Co Ltd (017180.KS) is -1.63%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -1.63% |
| 2023-12-31 | -2.67% |
| 2022-12-31 | 5.17% |
| 2021-12-31 | -4.74% |
| 2020-12-31 | -21.62% |
| 2019-12-31 | -13.66% |
| 2018-12-31 | 0.67% |
| 2017-12-31 | 5.57% |
| 2016-12-31 | 4.74% |
| 2015-12-31 | -12.90% |